NICE has published the papers for its upcoming public board meeting on 22nd May in Dorset.
The papers include interesting insights into the reason for delays in NICE technology appraisals, NICE’s plans to widen evidence bases in its work and also an update from the Centre for Health Technology Evaluation (CHTE).
In the papers, the Chief Executive’s report analyses the performance of NICE throughout the 2018/19 business year. This includes reasons for delays in NICE technology appraisals, which are summarised as:
‘The majority of the topics delayed (74%) fall into two categories: topics rescheduled due to regulatory approval timeline changes or suspended due to negative regulatory decisions, and topics delayed after draft guidance publication, to accommodate commercial discussion with NHS England. The remainder of the delayed topics are either the result of company requests for more time to submit data or analysis, or to non-submission of data by companies.’
The papers continue by outlining NICE’s statement of intent for consultation. This statement is:
‘Widening the evidence base: the use of broader data and applied analytics in NICE’s work.’
In expanding on this statement, NICE outline the broader scope of data that it proposes to use in its work and the occasions where it proposes to use it.
The papers also include a review of the work of the CHTE over the 2018/19 business year.
This information includes some interesting insights regarding the levels of approval and delays in NICE technology appraisals over the past business year.
Read more from the papers here.